Mepolizumab Long-term Access Program for Subjects who Participated in Study MEA115921 (Placebo-controlled Study of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving Standard-of-care Therapy)
Eosinophilic granulomatosis with polyangiitis (also known as Churg–Strauss syndrome) is a rare autoimmune condition that causes inflammation. This study is not seeking to enroll additional patients.
Kim Glorieux, CRC: 425.635.6082, Kimberly.Glorieux@overlakehospital.org
Clinical Trial Categories